
NSE: GLAND · Healthcare · Pharmaceuticals · Market cap ₹55,341 Cr
· Prev close ₹3,132.80 · Volume 18.04 L · 52W ₹1,574–3,354
Day range for 9 Nov not in the price history yet · 8 Nov ₹3,082.20–3,199.00
Same session as: Announcement under Regulation 30 (LODR)-Change in Management, filed 9 Nov 2026, 9:55 am IST
Generated • Gland Pharma appointed Mr.
Shown when the day move is above 5%: the most material filing of this session and the one before.
Last 4 quarters: profit +56.3% on the 4 beforeShare price +1.7% in a month
Current ratio Not in our data
Needs current assets and current liabilities from the latest annual balance sheet filed with the exchange.
100%: all profit arrived as cash
| Year | Operating cash | Net profit | Conversion |
|---|---|---|---|
| FY22 | 791 | 1,212 | 65% |
| FY23 | 364 | 781 | 47% |
| FY24 | 997 | 772 | 129% |
| FY25 | 915 | 699 | 131% |
| FY26 | 1,031 | 1,027 | 100% |
| FY22–26 | 4,098 | 4,491 | 91% |